Search Results 651-660 of 19298 for Myocardium

1. Cardiovascular Medicine - Clinical trials

   ... myocardial injury as assessed by changes in high sensitivity cardiac troponin T (hs-cTnT) assay. This will be done by comparing pre-and-post MRI hs-cTnT ...

2. Temozolomide and Irinotecan Hydrochloride with or without Bevacizumab in Treating Young Patients with Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors - Mayo Clinic

   Patients with a history of stroke, myocardial infarction, transient ischemic attack (TIA), severe or unstable angina, peripheral vascular disease, or grade ...

3. A Study to Evaluate Trifluridine/Tipiracil Combined with Bevacizumab vs Trifluridine/Tipiracil to Treat Patients with Refractory Metastatic Colorectal Cancer - Mayo Clinic

   Deep arterial thromboembolic events including cerebrovascular accident or myocardial infarction within the last 6 months prior to randomization. Treatment ...

4. A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab - Mayo Clinic

   myocardial infarction < 6 months prior to study entry;; unstable angina;; congestive heart failure (New York Heart Association Classification ≥ Class II); ...

5. Study of Canakinumab in Patients With Myelofibrosis - Mayo Clinic

   - Myocardial infarction ≤ 6 months prior to enrollment; - Unstable angina pectoris designated by treating physician; - Serious uncontrolled cardiac ...

6. Study to Evaluate Mechanisms of Immunomodulator Sensitivity and Resistance in Multiple Myeloma - Mayo Clinic

   History of myocardial infarction ≤ 6 months. Eligibility last updated 11/28/22. Questions regarding updates should be directed to the study team contact ...

7. Study Evaluating The Safety And Efficacy Of Fenfluramine Hydrochloride Oral Solution As Adjunctive Therapy In Children With Doose Syndrome - Mayo Clinic

   Current or past history of cardiovascular or cerebrovascular disease, such as cardiac valvulopathy, myocardial infarctions, or stroke. Current or recent ...

8. Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Estrogen Receptor Positive (ER+) Breast Cancer - Mayo Clinic

   History of acute coronary syndromes (including unstable angina and myocardial infarction), coronary angioplasty, or stenting within the past 3 months.

9. Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies - Mayo Clinic

   Symptomatic Congestive heart failure, ischemia, conduction abnormalities, or myocardial infarction within 6 months. Acute active infection requiring ...

10. Autologous Stem Cell Transplant Clinical Trials - Mayo Clinic Research

    ... myocardium of the right ventricle of subjects with Ebstein anomaly undergoing surgical Ebstein repair. Additionally, the potential cardiovascular benefits ...